A study to find the capability&safety of a new device named AnaConDA by giving sleep inducing medication to operated adult patients who require mechanical ventilation (artificial breathing through machine)
- Conditions
- Health Condition 1: R00-R09- Symptoms and signs involving the circulatory and respiratory systems
- Registration Number
- CTRI/2020/04/024437
- Lead Sponsor
- Dept of Anaesthesia Critical Care and Pain Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Age 50-80 years
2.Weight 50-120 kg
3.Elective post-operative patients anticipated to require sedation between 12 -24 for elective mechanical ventilation.
4.Hemodynamically stable patients (not requiring more than 0.3 microgram/kg/min of noradrenaline)
5.Patients willing to participate in the trial by giving written informed consent.
1.Contraindications to use of HME filter during mechanical ventilation, these may include, but not limited to: excessive secretions or pulmonary hemorrhage likely to block the filter, indications for reducing apparatus dead space.
2.Head trauma and neurosurgical patients or mental obtundation due to any other reason preoperatively.
3.Patients with raised ICP.
4.Low GCS ( <9).
5.Pregnant or breast feeding women.
6.Family or personal history of malignant hyperthermia.
7.Patients already receiving sedation for more than >6 hours.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method